Jan 8, 2025
Experienced Industry Leader Dr. Joerg Moeller Appointed as Chief Executive Officer of Antag Therapeutics
Read More
Jan 7, 2025
Novel Heart Failure Technology from Alleviant Medical Gains FDA Approval for New Pivotal Trial and Breakthrough Designation for Significant Patient Population
Read More
Dec 11, 2024
RapidPulse Receives FDA Approval to Begin IDE Study in Ischemic Stroke Using Innovative Cyclic Aspiration System – Recently Completed Clinical Trial Shows Significantly Higher First Pass and Frontline Success Rates
Read More
Dec 6, 2024
Alveron Pharma Announces Close of €5M Seed Extension Financing, led by Broadview Ventures, to Accelerate Breakthrough Therapy for Intracranial Haemorrhage
Read More
Dec 4, 2024
Antag Therapeutics Announces €80 Million Series A Financing
Read More
Dec 2, 2024
XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio
Read More
2345678